Nektar Therapeutics (NKTR) FCF Margin Growth (3y) (2013 - 2026)
Nektar Therapeutics (NKTR) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 15,064.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Nektar Therapeutics | 1.76 Bn | 1.19 Bn | 3.16 Mn | -16,561.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,561.00 |
| Dec 31, 2025 | -3,363.00 |
| Sep 30, 2025 | -6,294.00 |
| Jun 30, 2025 | -5,857.00 |
| Mar 31, 2025 | -9,581.00 |
| Dec 31, 2024 | 46,963.00 |
| Sep 30, 2024 | 23,274.00 |
| Jun 30, 2024 | 14,291.00 |
| Mar 31, 2024 | 11,611.00 |
| Dec 31, 2023 | 22,991.00 |
| Sep 30, 2023 | 716.00 |
| Jun 30, 2023 | -7,485.00 |
| Mar 31, 2023 | -8,626.00 |
| Dec 31, 2022 | 11,631.00 |
| Sep 30, 2022 | -9,847.00 |
| Jun 30, 2022 | -6,983.00 |
| Mar 31, 2022 | -6,651.00 |
| Dec 31, 2021 | -31,254.00 |
| Sep 30, 2021 | -15,382.00 |
| Jun 30, 2021 | -39,218.00 |